vTv Therapeutics Inc.
VTVT
$25.24
$1.747.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -98.30% | -98.30% | -98.30% | -- | 11,011.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -98.30% | -98.30% | -98.30% | -- | 11,011.11% |
| Cost of Revenue | -39.96% | -72.14% | -68.70% | -75.20% | 5.68% |
| Gross Profit | 34.54% | 69.70% | 64.55% | 86.68% | 3.47% |
| SG&A Expenses | 0.74% | 3.44% | 7.63% | 14.65% | 15.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.35% | 7.47% | 1.50% | -1.20% | -7.93% |
| Operating Income | -24.26% | -12.10% | -5.71% | 5.18% | 11.58% |
| Income Before Tax | -25.52% | 5.67% | 12.29% | 12.94% | 18.13% |
| Income Tax Expenses | -100.00% | -100.00% | -100.00% | -- | -- |
| Earnings from Continuing Operations | -24.97% | 6.04% | 12.62% | 12.56% | 17.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 11.49% | -17.45% | -24.68% | -25.77% | -27.80% |
| Net Income | -28.21% | 3.08% | 9.35% | 8.83% | 14.92% |
| EBIT | -24.26% | -12.10% | -5.71% | 5.18% | 11.58% |
| EBITDA | -24.57% | -12.29% | -5.79% | 5.20% | 11.62% |
| EPS Basic | 28.42% | 51.46% | 63.78% | 69.14% | 60.35% |
| Normalized Basic EPS | 26.42% | 49.67% | 62.37% | 71.25% | 61.99% |
| EPS Diluted | 28.42% | 51.46% | 63.78% | 69.14% | 60.35% |
| Normalized Diluted EPS | 26.42% | 49.67% | 62.37% | 71.25% | 61.99% |
| Average Basic Shares Outstanding | 58.06% | 48.49% | 97.70% | 197.91% | 145.39% |
| Average Diluted Shares Outstanding | 58.06% | 48.49% | 97.70% | 197.91% | 145.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |